| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 112529-18-7 | 1,O(6)-Ethanoguanosine | C12H16N5O5 |
| 112529-19-8 | 4-[2-Bromo-1-(4-Hydroxyphenyl)-2-Phenylethyl]Phenol | C20H17BrO2 |
| 112529-49-4 | 16alpha,17-Epoxycorticosterone 21-Acetate | C23H30O6 |
| 112531-75-6 | Dichloro[1,2-Ethanediylbis[(1,2,3,3a,7a-H)-4,5,6,7-Tetrahydro-1H-Inden-1-Ylidene]]-Titanium | |
| 112533-64-9 | 2-[4-[3-[(4-Amino-3-Iodophenyl)Methyl]-2,6-Dioxo-1-Propyl-7H-Purin-8-Yl]Phenoxy]Acetic Acid | C23H22IN5O5 |
| 112537-82-3 | 1-(4-Methyl-1-Piperidinyl)-2-Phenylethanethione | C14H19NS |
| 112537-96-9 | 5-Nitro-2-2-furaldehydezine | C10H6N4O6 |
| 112538-45-1 | 3-Acetyl-2-Imino-1-Methyl-Imidazolidin-4-One | C6H9N3O2 |
| 112538-92-8 | 3-Hydroxyheptadecanoic Acid Methyl Ester | C18H36O3 |
| 112539-08-9 | 2-Amino-4-Thiazolecarboxylic Acid Hydrobromide (1:1) | C4H5BrN2O2S |
| 112539-09-0 | 4-(2-Oxopyrrolidin-1-yl)benzene-1-sulfonyl chloride | C10H10ClNO3S |
| 112540-82-6 | (1-34)-Humanhumoral hypercalcemic factor | |
| 112543-66-5 | 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid | C9H16O9 |
| 112549-07-2 | 2,3,4,5-Tetramethyl-1-Phenyl-1H-Phosphole | C14H17P |
| 112558-45-9 | N-(L-Prolyl)-beta-alanine | C8H14N2O3 |
| 112559-69-0 | 2-[2-(3-Oxobutyl)]-4-{4-[4-(4-hydroxyphenyl)-piperazin-1-yl]-phenyl}-2,4-dihydro-[1,2,4-triazol-3-one | C22H25N5O3 |
| 112559-81-6 | 4-(4-(4-Nitrophenyl)-1-piperazinyl)phenol | C16H17N3O3 |
| 112559-91-8 / 148626-66-8 | Hydroxyitraconazole | C35H38Cl2N8O5 |
| 112560-33-5 | 4-{4-[4-(4-{[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-Triazol-1-Ylmethyl)-1,3-Dioxolan-4-Yl]Methoxy}Phenyl)-1-Piperazinyl]Phenyl}-2-(3-Oxo-2-Butanyl)-2,4-Dihydro-3H-1,2,4-Triazol-3-One | C35H36Cl2N8O5 |
| 112562-63-7 | 2-[3-(4-Methyl-1-Piperazinyl)Propoxy]Benzaldehyde | C15H22N2O2 |
| 112565-42-1 | 2-(2-Pyrrolidinyl)-1H-Indole | C12H14N2 |
| 112565-82-9 | 3-Boryl-2-Methyl-2,3-Dihydro-1,3-Benzothiazole | C8H10BNS |
| 112566-17-3 | 2-Chloroimidazo[1,2-a]pyridine-3-sulfonamide | C7H6ClN3O2S |
| 112566-20-8 | Imidazo[1,2-a]pyridin-2-ol | C7H6N2O |
| 112568-12-4 | Antide | C82H108ClN17O14 |
| 112570-97-5 | 3-(5-Fluoro-2,4-dinitroanilino)-1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidine | C14H16FN4O5 |
| 112570-98-6 | 2-(1,2,4-Oxadiazol-3-Yl)Pyrazine | C6H4N4O |
| 112571-38-7 | (3R,4R)-3,4-Di-O-benzyl-1,5-hexadiene-3,4-diol | C20H22O2 |
| 112571-68-3 | DL-myo-Inositol 1,4,5-Trisphosphate Hexaammonium Salt | C6H33N6O15P3 |
| 112571-69-4 | D-Myo-Inositol 1,4,5-Tris(Dihydrogen Phosphate) Hexaammonium Salt | C6H24N3O15P3 |
| 112573-72-5 | Phenylmethyl 2-[[(2R)-2-(Acetylsulfanylmethyl)-3-Phenylpropanoyl]Amino]Acetate | C21H23NO4S |
| 112573-73-6 | Phenylmethyl 2-[[(2S)-2-(Acetylsulfanylmethyl)-3-Phenylpropanoyl]Amino]Acetate | C21H23NO4S |
| 112574-71-7 | (2R,3S)-3-(Methoxycarbonyl)-2-Oxiranecarboxylic Acid | C5H6O5 |
| 112574-77-3 | Methyl 8-Methyl-3-Oxo-8-Azabicyclo[3.2.1]Octane-2-Carboxylate | C10H15NO3 |
| 112575-11-8 | (6-Bromopyridin-2-yl)acetonitrile | C7H5BrN2 |
| 112575-13-0 | 6-Bromo-2-(dimethylamino)pyridine | C7H9BrN2 |
| 112575-63-0 | Bwa 947U | C24H22IN7O5 |
| 112575-84-5 | 4-(1H-Pyrrol-1-Yl)Benzohydrazide | C11H11N3O |
| 112576-12-2 | (R)-1-(naphthalen-2-yl)propan-1-ol | |
| 112576-45-1 | 7-Ethoxy-3,7-Dimethyloct-1-Ene | C12H24O |
| 112579-43-8 | 3-Methyl-4-Oxo-4,5,6,7-Tetrahydro-1-Benzofuran-2-Carboxylic Acid | C10H10O4 |
| 112581-60-9 | 2,6-Dichloroimidazo[1,2-a]Pyridine | C7H4Cl2N2 |
| 112581-74-5 | 2,5,7-Trimethylpyrazolo[1,5-a]Pyrimidine | C9H11N3 |
| 112581-77-8 | 2,6-Dichloroimidazo[1,2-b]pyridazine | C6H3Cl2N3 |
| 112581-95-0 | 2-Bromoimidazo[1,2-a]pyridine | C7H5BrN2 |
| 112582-18-0 | Imidazo[1,5-a]Pyridine-3-Sulfonamide | C7H7N3O2S |
| 112582-51-1 | Imidazo[1,5-a]Pyridine-1-Sulfonamide | C7H7N3O2S |
| 112582-68-0 | Pyrazolo[1,5-a]Pyrimidine-3-Sulfonamide | C6H6N4O2S |
| 112582-89-5 | 6-Chloroimidazo[2,1-b][1,3]Thiazole-5-Sulfonamide | C5H4ClN3O2S2 |
| 112583-13-8 | Imidazo[1,2-a]Pyridine-3-Sulfonamide | C7H7N3O2S |